ARCHIVES

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

NS Offers Research Grants, Scholarships

September 22, 1989

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010

Broder Encourages Support Of Drug Development Programs

March 10, 1995

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011